Zara has just released an entire London-inspired collection to celebrate 20 years since it launched its Regent Street store. The British collection will make you look like an extra member of the royal family, as everything is in the Windsor family’s unofficial uniform: tartan.
Up to 300 patients in England are to test a novel insulin pen accessory able to record usage data as part of a national NHS Test Bed programme exploring new models of care.
Under NHS England’s Test Bed initiative, NHS sites evaluate the real world impact of new technologies that have the potential to offer both better care and better value for taxpayers, with a view to rolling them out across the nation if they prove successful.
InsulCheck Connect is a snap-on accessory for disposable insulin pen users developed by Irish med tech group Innovation Zed, that automatically collects and records pen usage and behaviour data ‘on the go’.
The device, which will assessed within the South Yorkshire and Bassetlaw Perfect Patient Pathway Test Bed, is to be offered to diabetic patients at the Northern General Hospital, Sheffield, as part of a programme designed to better support them to manage their condition.
The concept is to marry the data collected by InsulCheck Connect with other key information such as sugar level readings to create a new package of support for diabetic patients that will enable them and their medical professionals to improve the management of the condition and thus secure better health outcomes.
“Our research with insulin pen users highlights that, as with other conditions, injection compliance is significantly below what is prescribed. We firmly believe that this work will demonstrate that our insulin pen accessory can greatly improve injection compliance and generate better health outcomes for people with diabetes,” said John Hughes, Innovation Zed’s chief executive.
http://www.pharmatimes.com/news/nhs_to_assess_data-recording_insulin_pen_device_1203468
Top 10 Attractions
Visitors as well as locals can benefit from the activities that are different that are many . Enjoy under billions of twinkles star’s while saving your budget with Overnight Desert Safari the best choice & better option than spending on hotel stay. Please yourself with night stay inside Dubai Desert after entertaining yourself with BBQ Dinner & food, by traditional atmosphere & shows with sleeping bags & tents. Explore the beauty of its secrets and the desert within. Get a taste of the Arabic customs and culture and enrich your knowledge and experiences in life. Today check our tour packages, fill in the booking form, and prepare for your next travel adventure.Try like you can go with Dubai City Tour to get in less more and take benefit of Dubai City Tour with the possibility to snap fantasies with monstrous landmarks like Burj Khalifa & Burj Al Arab. If you are adventure fan then the 1st choice of Adventure in Dubai is Dubai Desert Safari with a complete live performances arrangement, BBQ and much more activity are bounded without paying extra cost.Dubai Desert Safari is a leading tour operator in the United Arab Emirates. Proving excellence in Dubai Desert Safari Services and Capturing Millions of tourist’s heart since 2012. We have Licensed aiming to provide an kind of service and delivers the promise. Dubai Desert Safari is the tourist and mainstream magnet in Dubai, which has been toured by the millions of tourist every year & placing Dubai’s map at Global Tourism.At night, you may observe the inspiring and vibrant series such as Live Belly Dance, Tanura Dance, Arabic Halla Dance Fire Show & one of a kind Puppet Play for children’s performed plan to all guest. You will finish your night in the Desert Safari Dubai Camp by being a stargazer under the Billions of star. As of many years of successfully providing excellence of solutions, Dubai Evening Safari asked by the millinery of tourist throughout the world and has been proven. As a component of Trip Advisor, We are the tour operator seeing exceptional Desert Safari experience. Wish you a Dubai Desert Safari occasion with your loved one.Dubai is an excellent and hypnotizing area which has a substantial measure. Whether you want to see terrains or building design that is wonderful and some incomprehensible portraying nature taking care of business, you will get everything here. One of the things which you can not miss in Dubai will be desert safari Dubai. Guests and, too people can exploit the particular exercises in Dubai city. These visitor exercises incorporate desert safari outings in Dubai. We should find some answers concerning those exercises which make for the Arabian experience.In the tourist life all the time more adventure and adventures come, but only Desert Safari Dubai Experience is. You can get joy of Dubai, Hatta mountain & Abu Dhabi desert safari, An authentic desert safari, this excursion features luxurious 4 x 4 vehicles that pick guests up from their hotel for an evening of amazing journey.
You can read more about at dubaiadventure.net evening desert safari
, an UAE Tour Operator.
Who plans vacations with their kids happyness in mind but also looking for a hot and sunny location ? For these people i have an answer : Orlando, Florida. It’s sunny, warm, relaxed and kids can enjoy the Disneyland attraction, for unfogetable memories and a dream holiday.
gamban works with organisations around the world to provide free protection for staff. Once a company has been ‘white-listed’ unlimited members of staff can obtain free protection on up to three devices with a verified email address.
Among the different types of travel, bicycle tours safely enjoy by far the largest popularity in addition to hiking. Therefore today, many hotels in Germany offer rental bikes. One is able to put together his own break in connection with a site hotel.
The famous American vaccine company Profectus settled in Hong Kong
First recommend HPV cervical cancer treatment vaccine
BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018
Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, established clinical network and market access capabilities, expected in the second half of 2018 to put into operation.
The company’s first product development program will focus on the development, production and commercial application of prophylactic and therapeutic vaccines for HPV (human papillomavirus)-related lesions and cervical cancer [based on PBSVax® technology developed by Profectus]. ProMed BioSciences also plans to develop and treat hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Chikungunya and Zika, as well as personalized vaccines to treat cancer. The joint venture is expected to launch new vaccines in their respective markets, which will help promote the development of new vaccines, but ultimately the goal is to benefit patients around the world.
Mr. Jeffery Meshulam (first from left), President of Profectus Biotechnology, Mr. Terry Lierman (second from left), Chairman of Medivh Medical Group, and Mr. Danny Wong (fourth from right), founder and executive chairman of Medisun Medical Group, at Profectus ,USA.
– Long-term strategic cooperation to address the huge demand for prevention and treatment of infectious diseases and cancer in Asia
-Profectus’ expertise in vaccine development and platform technology, combined with Medisun’s localized expertise and experience, to establish a leading Hong Kong vaccine company focused on serving Asia
“This strategic cooperation will help establish Profectus’ business in Hong Kong and China. Through close cooperation with Medisun, we can assist Hong Kong and China to develop advanced vaccine technology to help prevent and treat Asian patients. Mr. Jeffrey Meshulam, President of Profectus, said, “We are pleased to be able to work with recognized local partners to achieve the highest standards of scientific research and development integration and medical services.”
“This collaboration will help Profectus and Medisun to jointly produce life-saving vaccines for infectious diseases and cancer, and address the huge medical needs that have not been met in Hong Kong, China and Asia.” Mr. Danny Wong, founder and executive chairman of Medisun Medical Group, said “ProMed BioSciences will leverage Profectus’ expertise in vaccine development and technology, combined with Medisun’s local expertise and close links with healthcare facilities in Hong Kong and China, and government medical regulatory agencies to develop vaccines to provide leadership for Asian patients disease prevention and treatment programs.”
ProMed BioSciences will focus on the following:
• Conduct technical research in Hong Kong or China
• Conduct clinical trials in Hong Kong or China
• Promote the expansion of Medisun Medical Center
• Develop vaccines to address disease prevention needs
• leverage to maximize the expertise of both partners
Mr. Jeffery Meshulam, President of Profectus Biotechnology (first from left), Mr. Terry Lierman, Chairman of Medisun Medical Group (first from right), Mr. Danny Wong, founder and executive chairman of Medisun Medical Group (middle), at the US headquarters of Profectus.
About ProMed BioSciences
ProMed BioSciences Limited is a joint venture between Profectus BioSciences (USA) and Medisun Medical Group (Hong Kong) in Hong Kong to develop and conduct new vaccine clinical trials and commercial applications to address infectious diseases and cancer in Asia with the huge demand for prevention and treatment.
About Medisun
Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative Medisunne products, as well as quality hospitals and treatment centers. Medisun invests extensively in the fields of regenerative and stem cell patent technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, nervous system disease, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun and Harvard University Stem Cell Research Institute, Johns Hopkins Medical School Life Science Center, Tsinghua University and other institutions have long-term cooperation plans to jointly invest in regenerative and stem cell therapy technology, with Medisun as a cooperative business The holding entity and holds global intellectual property rights. Medisun and the University of Maryland’s Institute of Human Virology (IHV) set up a technology clinical trial and development platform for viruses and cancer. Based on the Medisun Biomedical Laboratory in Hong Kong, Radiation will jointly build medical clinics in China and Asia. The experimental resource network promotes the world’s largest clinical research and development platform for virus research and cancer treatment technology. The Medisun Reproductive Centre is located at the Proud Square in Kowloon Bay, Hong Kong. It has a 50,000 square foot stem cell GMP production base, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to develop a rigorous and professional R&D process. Provides immune cell therapy and a variety of stem cell health treatments.
For more information, please visit http://www.medisun.hk/
About Profectus BioSciences
Profectus BioSciences is a clinical stage vaccine development company focused on developing new vaccines for infectious disease and cancer prevention and treatment. The Profectus vaccine is based primarily on the company’s proprietary VesiculoVax™ and DNA vaccine technology platform. By simply using the VesiculoVax™ vaccine alone, B cells can be rapidly expanded to provide protection against emerging infectious diseases that threaten public health and biodefense mechanisms, such as Ebola, Marburg, Chikungunya, Zika virus, equine encephalitis virus, and respiratory syncytial virus. When VesiculoVax™ is used as a vaccine when the immune system is launched with the best pDNA vaccine, the Vesiculo Vax™-directed vaccine expands the triggered T cells into effector cells, which are ideal for attacking virus-infected cells and cancer. Current projects using the Prime / Boost Vaccine System (PBS Vax™) strategy include hepatitis B virus (HBV), human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus ( HIV). Partners and collaborators include UTMB’s Galveston National Laboratory, Yale University, University of Maryland Human Virology Institute, HIV/AIDS Vaccine Immunology Center, National Cancer Institute, National Institutes of Health AIDS Division, Bill And the Melinda Gates Foundation, the International AIDS Vaccine Initiative, the AIDS Vaccine Trial Network and the AIDS Clinical Trial Group. Profectus is funded by Cross Atlantic Capital Partners (“XACP”) in Radnor, Pennsylvania. The main investor in XACP is the Pennsylvania Public School Employees Retirement System (“PSERS”). For more information, please visit www.profectusbiosciences.com
Mount Fuji (富士山, Fujisan) is with 3776 meters Japan’s highest mountain. It is not surprising that the nearly perfectly shaped volcano has been worshiped as a sacred mountain and experienced big popularity among artists and common people throughout the centuries.
Sony Interactive Entertainment America has announced that a new Collections feature has joined the ranks of its PlayStation Now lineup, a handy option that bundles together titles based on platform, genre, and themes.
In addition to Collections, the format holder also revealed that it has added 11 new games to PS Now, including Mafia III and Steep See the full list below.
A lot of the attention surrounding this year’s BlizzCon was naturally focused on major announcements such as Diablo Immortal and Hearthstone’s Rastakhan’s Rumble expansion. However, a little time was set aside for StarCraft II as well, specifically during the ‘StarCraft II: What’s Next’ panel.